(Q40888434)

24 September 2017

1 reference

title

Empiric antibiotic therapy of abdominal sepsis and serious perioperative infections (English)

1 reference

24 September 2017

0 references

Shands JW Jr

1

1 reference

24 September 2017

publication date

1 April 1993

1 reference

Surgical Clinics of North America

24 September 2017

published in

1 reference

24 September 2017

volume

73

1 reference

24 September 2017

issue

2

1 reference

24 September 2017

page(s)

291-306

1 reference

Diagnosis of nosocomial bacterial pneumonia in acute, diffuse lung injury

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945982-7

7 January 2021

Therapeutic efficacy of 29 antimicrobial regimens in experimental intraabdominal sepsis.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945982-7

7 January 2021

Bacteriology of hospital-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945982-7

7 January 2021

Toxic shock syndrome associated with surgical wound infections

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945982-7

7 January 2021

Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945982-7

7 January 2021

Guidelines for clinical care: anti-infective agents for intra-abdominal infection. A Surgical Infection Society policy statement

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945982-7

7 January 2021

Postoperative necrotizing fasciitis of the abdominal wall

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945982-7

7 January 2021

Ceftazidime versus tobramycin-ticarcillin in the treatment of pneumonia and bacteremia

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945982-7

7 January 2021

Role of enterococcus in intraabdominal sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945982-7

7 January 2021

Detection of nosocomial lung infection in ventilated patients. Use of a protected specimen brush and quantitative culture techniques in 147 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945982-7

7 January 2021

Risk factors for postoperative pneumonia.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945982-7

7 January 2021

Once-daily aminoglycoside therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945982-7

7 January 2021

Bacteriology of necrotizing fasciitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945982-7

7 January 2021

Postoperative wound infection: a controlled study of the increased duration of hospital stay and direct cost of hospitalization

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945982-7

7 January 2021

Failure of antisera to J5 and R595 rough mutants to reduce endotoxemic lethality.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945982-7

7 January 2021

Prospective, randomized comparative study of clindamycin, chloramphenicol, and ticarcillin, each in combination with gentamicin, in therapy for intraabdominal and female genital tract sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945982-7

7 January 2021

Prospective, randomized, comparative trials in the therapy for intraabdominal and female genital tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945982-7

7 January 2021

Perforated and Gangrenous Appendicitis: An Analysis of Antibiotic Failures

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945982-7

7 January 2021

Antibodies to Core Lipopolysaccharide Determinants: Absence of Cross-reactivity with Heterologous Lipopolysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945982-7

7 January 2021

Role of aminoglycoside antibiotics in the treatment of intra-abdominal infection

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945982-7

7 January 2021

Changing pharyngeal bacterial flora of hospitalized patients. Emergence of gram-negative bacilli.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945982-7

7 January 2021

Association of Respiratory Tract Colonization with Adherence of Gram-Negative Bacilli to Epithelial Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945982-7

7 January 2021

Bacteriologic diagnosis of nosocomial pneumonia following prolonged mechanical ventilation

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945982-7

7 January 2021

Evaluation of antibiotic therapy following penetrating abdominal trauma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945982-7

7 January 2021

Cefoperazone versus ceftazidime monotherapy of nosocomial pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945982-7

7 January 2021

Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945982-7

7 January 2021

Postoperative wound infection

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945982-7

7 January 2021

Empiric Antibiotic Therapy for Intraabdominal Infections

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945982-7

7 January 2021

Risk of infection after penetrating abdominal trauma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945982-7

7 January 2021

Coagulopathy associated with extended-spectrum cephalosporins in patients with serious infections

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945982-7

7 January 2021

Pneumonia treated with imipenem/cilastatin.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945982-7

7 January 2021

Type I beta-lactamases of gram-negative bacteria: interactions with beta-lactam antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945982-7

7 January 2021

Major trends in the microbial etiology of nosocomial infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945982-7

7 January 2021

A Randomized Clinical Trial of Moxalactam Alone versus Tobramycin plus Clindamycin in Abdominal Sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945982-7

7 January 2021

Timentin in the treatment of nosocomial bronchopulmonary infections in intensive care units

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945982-7

7 January 2021

Cross-reactivity of rabbit antibodies to lipopolysaccharides of Escherichia coli J5 and other gram-negative bacteria.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945982-7

7 January 2021

Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intra-abdominal infections

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945982-7

7 January 2021

Antibiotic trials in intra-abdominal infections. A critical evaluation of study design and outcome reporting.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945982-7

7 January 2021

A randomized comparison of cefoxitin with or without amikacin and clindamycin plus amikacin in surgical sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945982-7

7 January 2021

Randomized prospective study comparing moxalactam and cefoxitin with or without tobramycin for the treatment of serious surgical infections

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945982-7

7 January 2021

Use of ceftazidime in the treatment of nosocomial lower respiratory infections

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945982-7

7 January 2021

Anti-endotoxin monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945982-7

7 January 2021

Antimicrobial Therapy of Experimental Intraabdominal Sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945982-7

7 January 2021

Role of fibronectin in the prevention of adherence of Pseudomonas aeruginosa to buccal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945982-7

7 January 2021

Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945982-7

7 January 2021

10.1016/S0039-6109(16)45982-7

Identifiers

DOI

0 references

1 reference